{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:45:38Z","timestamp":1792802738329,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-024-01632-y","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T21:28:07Z","timestamp":1734125287000},"page":"2213-2226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring Thiazolidinedione-Naphthalene Analogues as Potential Antidiabetic Agents: Design, Synthesis, Molecular Docking and In-vitro Evaluation"],"prefix":"10.1007","volume":"83","author":[{"given":"Sharfuddin","family":"Mohd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vancha","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govindaiah","family":"Pilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"issue":"17","key":"1632_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Mart\u00edn, C. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences, 21(17), 1\u201334. https:\/\/doi.org\/10.3390\/ijms21176275.","journal-title":"International Journal of Molecular Sciences"},{"issue":"April","key":"1632_CR2","doi-asserted-by":"publisher","first-page":"103195","DOI":"10.1016\/j.bioorg.2019.103195","volume":"94","author":"R Rafique","year":"2020","unstructured":"Rafique, R., Khan, K. M., Kanwal, A., Chigurupati, S., Wadood, A., Rehman, A. U., Karunanidhi, A., Hameed, S., Taha, M., & al-Rashida, M. (2020). Synthesis of new indazole based dual inhibitors of \u03b1-glucosidase and \u03b1-amylase enzymes, their in vitro, in silico and kinetics studies. Bioorganic Chemistry, 94(April), 103195 https:\/\/doi.org\/10.1016\/j.bioorg.2019.103195.","journal-title":"Bioorganic Chemistry"},{"issue":"8","key":"1632_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25081987","volume":"25","author":"A Artasensi","year":"2020","unstructured":"Artasensi, A., Pedretti, A., Vistoli, G., & Fumagalli, L. (2020). Type 2 diabetes mellitus: a review of multi-target drugs. Molecules, 25(8), 1\u201320. https:\/\/doi.org\/10.3390\/molecules25081987.","journal-title":"Molecules"},{"issue":"10","key":"1632_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41574-020-0392-2","volume":"16","author":"AJ Scheen","year":"2020","unstructured":"Scheen, A. J. (2020). Sodium\u2013glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus. Nature Reviews Endocrinology, 16(10), 556\u2013577.","journal-title":"Nature Reviews Endocrinology"},{"key":"1632_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/271983","volume":"2015","author":"W-S Lee","year":"2015","unstructured":"Lee, W.-S., & Kim, J. (2015). Peroxisome proliferator-activated receptors and the heart: lessons from the past and future directions. PPAR Research, 2015, 1\u201318. https:\/\/doi.org\/10.1155\/2015\/271983.","journal-title":"PPAR Research"},{"issue":"1","key":"1632_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0167-0115(94)90136-8","volume":"51","author":"D Elahi","year":"1994","unstructured":"Elahi, D., McAloon-Dyke, M., Fukagawa, N. K., Meneilly, G. S., Sclater, A. L., Minaker, K. L., Habener, J. F., & Andersen, D. K. (1994). The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects. Regulatory Peptides, 51(1), 63\u201374. https:\/\/doi.org\/10.1016\/0167-0115(94)90136-8.","journal-title":"Regulatory Peptides"},{"key":"1632_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","volume":"30","author":"TD M\u00fcller","year":"2019","unstructured":"M\u00fcller, T. D., Finan, B., Bloom, S. R., D\u2019Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., & Habener, J. F. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72\u2013130.","journal-title":"Molecular Metabolism"},{"issue":"4","key":"1632_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccl.2008.06.008","volume":"26","author":"JH Wani","year":"2008","unstructured":"Wani, J. H., John-Kalarickal, J., & Fonseca, V. A. (2008). Dipeptidyl peptidase-4 as a new target of action for type 2 diabetes mellitus: a systematic review. Cardiology Clinics, 26(4), 639\u2013648. https:\/\/doi.org\/10.1016\/j.ccl.2008.06.008.","journal-title":"Cardiology Clinics"},{"issue":"3","key":"1632_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2174\/1568008013341163","volume":"1","author":"BJ Goldstein","year":"2001","unstructured":"Goldstein, B. J. (2001). Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance. Current Drug Targets. Immune, Endocrine and Metabolic Disorders, 1(3), 265\u2013275. https:\/\/doi.org\/10.2174\/1568008013341163.","journal-title":"Current Drug Targets. Immune, Endocrine and Metabolic Disorders"},{"issue":"28","key":"1632_CR10","doi-asserted-by":"publisher","first-page":"17439","DOI":"10.1074\/jbc.M114.594937","volume":"290","author":"K Date","year":"2015","unstructured":"Date, K., Satoh, A., Iida, K., & Ogawa, H. (2015). Pancreatic \u03b1-amylase controls glucose assimilation by duodenal retrieval through N-glycan-specific binding, endocytosis, and degradation. Journal of Biological Chemistry, 290(28), 17439\u201317450. https:\/\/doi.org\/10.1074\/jbc.M114.594937.","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"1632_CR11","first-page":"303","volume":"18","author":"H Bischoff","year":"1995","unstructured":"Bischoff, H. (1995). The mechanism of alpha-glucosidase inhibition in the management of diabetes. Clinical and Investigative Medicine. Medecine Clinique et Experimentale, 18(4), 303\u2013311.","journal-title":"Clinical and Investigative Medicine. Medecine Clinique et Experimentale"},{"issue":"3","key":"1632_CR12","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1039\/d2ra07247e","volume":"13","author":"MG Srinivasa","year":"2023","unstructured":"Srinivasa, M. G., Paithankar, J. G., Saheb Birangal, S. R., Pai, A., Pai, V., Deshpande, S. N., & Revanasiddappa, B. C. (2023). Novel hybrids of thiazolidinedione-1,3,4-oxadiazole derivatives: synthesis, molecular docking, MD simulations, ADMET study, in vitro, and in vivo anti-diabetic assessment. RSC Advances, 13(3), 1567\u20131579. https:\/\/doi.org\/10.1039\/d2ra07247e.","journal-title":"RSC Advances"},{"key":"1632_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2165\/00003495-198835030-00003","volume":"35","author":"SP Clissold","year":"1988","unstructured":"Clissold, S. P., & Edwards, C. (1988). Acarbose: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs, 35, 214\u2013243.","journal-title":"Drugs"},{"issue":"3","key":"1632_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2165\/00003495-200059030-00012","volume":"59","author":"LJ Scott","year":"2000","unstructured":"Scott, L. J., & Spencer, C. M. (2000). Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus. Drugs, 59(3), 521\u2013549.","journal-title":"Drugs"},{"key":"1632_CR15","doi-asserted-by":"publisher","unstructured":"Dabhi, A. S., Bhatt, N. R., & Shah, M. J. (2013). Voglibose: an alpha glucosidase inhibitoris. Journal of Clinical and Diagnostic Research, 7(12), 3023\u20133027. https:\/\/doi.org\/10.7860\/JCDR\/2013\/6373.3838.","DOI":"10.7860\/JCDR\/2013\/6373.3838"},{"key":"1632_CR16","doi-asserted-by":"publisher","first-page":"129920","DOI":"10.1016\/j.molstruc.2021.129920","volume":"1230","author":"S Chortani","year":"2021","unstructured":"Chortani, S., Horchani, M., Znati, M., Issaoui, N., Jannet, H., Ben, & Romdhane, A. (2021). Design and synthesis of new benzopyrimidinone derivatives: \u03b1-amylase inhibitory activity, molecular docking and DFT studies. Journal of Molecular Structure, 1230, 129920.","journal-title":"Journal of Molecular Structure"},{"issue":"3","key":"1632_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09045","volume":"8","author":"M Santoso","year":"2022","unstructured":"Santoso, M., Ong, L. L., Aijijiyah, N. P., Wati, F. A., Azminah, A., Annuur, R. M., Fadlan, A., & Judeh, Z. M. A. (2022). Synthesis, \u03b1-glucosidase inhibition, \u03b1-amylase inhibition, and molecular docking studies of 3,3-di(indolyl)indolin-2-ones. Heliyon, 8(3), e09045 https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09045.","journal-title":"Heliyon"},{"issue":"July","key":"1632_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106709","volume":"139","author":"M Kazempour-Dizaji","year":"2023","unstructured":"Kazempour-Dizaji, M., Mojtabavi, S., Sadri, A., Ghanbarpour, A., Faramarzi, M. A. & & Navidpour, L. (2023). Arylureidoaurones: synthesis, in vitro \u03b1-glucosidase, and \u03b1-amylase inhibition activity. Bioorganic Chemistry, 139(July), 106709","journal-title":"Bioorganic Chemistry"},{"issue":"1","key":"1632_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/07391102.2019.1704885","volume":"39","author":"M Duhan","year":"2021","unstructured":"Duhan, M., Singh, R., Devi, M., Sindhu, J., Bhatia, R., Kumar, A., & Kumar, P. (2021). Synthesis, molecular docking and QSAR study of thiazole clubbed pyrazole hybrid as \u03b1-amylase inhibitor. Journal of Biomolecular Structure and Dynamics, 39(1), 91\u2013107. https:\/\/doi.org\/10.1080\/07391102.2019.1704885.","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"1","key":"1632_CR20","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1080\/14756366.2022.2078969","volume":"37","author":"BA Khan","year":"2022","unstructured":"Khan, B. A., Hamdani, S. S., Ahmed, M. N., Hameed, S., Ashfaq, M., Shawky, A. M., Ibrahim, M. A. A., & Sidhom, P. A. (2022). Synthesis, X-ray diffraction analysis, quantum chemical studies and \u03b1-amylase inhibition of probenecid derived S-alkylphthalimide-oxadiazole-benzenesulfonamide hybrids. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 1464\u20131478.","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"issue":"2","key":"1632_CR21","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.4067\/S0717-97072020000204817","volume":"65","author":"M Rashid","year":"2020","unstructured":"Rashid, M., Shrivastava, N., & Husain, A. (2020). Synthesis and SAR strategy of thiazolidinedione: a novel approach for cancer treatment. Journal of the Chilean Chemical Society, 65(2), 4817\u20134832. https:\/\/doi.org\/10.4067\/S0717-97072020000204817.","journal-title":"Journal of the Chilean Chemical Society"},{"issue":"3","key":"1632_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules27030830","volume":"27","author":"MY Sameeh","year":"2022","unstructured":"Sameeh, M. Y., Khowdiary, M. M., Nassar, H. S., Abdelall, M. M., Amer, H. H., Hamed, A., & Elhenawy, A. A. (2022). Thiazolidinedione derivatives: in silico, in vitro, in vivo, antioxidant and anti-diabetic evaluation. Molecules, 27(3), 1\u201315. https:\/\/doi.org\/10.3390\/molecules27030830.","journal-title":"Molecules"},{"issue":"9","key":"1632_CR23","doi-asserted-by":"publisher","first-page":"2100517","DOI":"10.1002\/ardp.202100517","volume":"355","author":"K Kajal","year":"2022","unstructured":"Kajal, K., Singh, G., Pradhan, T., Bhurta, D., & Monga, V. (2022). The medicinal perspective of 2, 4\u2010thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: a review. Archiv Der Pharmazie, 355(9), 2100517.","journal-title":"Archiv Der Pharmazie"},{"issue":"December 2019","key":"1632_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103676","volume":"97","author":"N Trotsko","year":"2020","unstructured":"Trotsko, N., Golus, J., Kazimierczak, P., Paneth, A., Przekora, A., Ginalska, G., & Wujec, M. (2020). Design, synthesis and antimycobacterial activity of thiazolidine-2,4-dione-based thiosemicarbazone derivatives. Bioorganic Chemistry, 97(December 2019), 103676 https:\/\/doi.org\/10.1016\/j.bioorg.2020.103676.","journal-title":"Bioorganic Chemistry"},{"issue":"1","key":"1632_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1165\/rcmb.2009-0445OC","volume":"45","author":"M Zhu","year":"2011","unstructured":"Zhu, M., Flynt, L., Ghosh, S., Mellema, M., Banerjee, A., Williams, E., Panettieri, R. A., & Shore, S. A. (2011). Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells. American Journal of Respiratory Cell and Molecular Biology, 45(1), 111\u2013119. https:\/\/doi.org\/10.1165\/rcmb.2009-0445OC.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"1632_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ejmech.2014.11.061","volume":"90","author":"RK Sharma","year":"2015","unstructured":"Sharma, R. K., Younis, Y., Mugumbate, G., Njoroge, M., Gut, J., Rosenthal, P. J., & Chibale, K. (2015). Synthesis and structure\u2013activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2. European Journal of Medicinal Chemistry, 90, 507\u2013518. https:\/\/doi.org\/10.1016\/j.ejmech.2014.11.061.","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"2","key":"1632_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2174\/1871524915666150824154136","volume":"16","author":"AS Thakur","year":"2016","unstructured":"Thakur, A. S., Deshmukh, R., Jha, A. K., & Kumar, P. S. (2016). Synthesis and anticonvulsant effect of novel thiazolidinedione containing benzene-sulfonylurea and sulfonylthiourea derivatives. Central Nervous System Agents in Medicinal Chemistry, 16(2), 152\u2013157. https:\/\/doi.org\/10.2174\/1871524915666150824154136.","journal-title":"Central Nervous System Agents in Medicinal Chemistry"},{"issue":"1","key":"1632_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/10408444.2017.1351420","volume":"48","author":"MA Davidson","year":"2018","unstructured":"Davidson, M. A., Mattison, D. R., Azoulay, L., & Krewski, D. (2018). Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology, 48(1), 52\u2013108.","journal-title":"Critical Reviews in Toxicology"},{"issue":"1","key":"1632_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bone.2005.07.008","volume":"38","author":"OP Lazarenko","year":"2006","unstructured":"Lazarenko, O. P., Rzonca, S. O., Suva, L. J., & Lecka-Czernik, B. (2006). Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat. Bone, 38(1), 74\u201384.","journal-title":"Bone"},{"issue":"1","key":"1632_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13065-021-00766-x","volume":"15","author":"M Hawash","year":"2021","unstructured":"Hawash, M., Jaradat, N., Shekfeh, S., Abualhasan, M., Eid, A. M., & Issa, L. (2021). Molecular docking, chemo-informatic properties, alpha-amylase, and lipase inhibition studies of benzodioxol derivatives. BMC Chemistry, 15(1), 40.","journal-title":"BMC Chemistry"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01632-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01632-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01632-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:27:35Z","timestamp":1747639655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01632-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1632"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01632-y","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"21 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}